The Salmon Oil OmeGo Reduces Viability of Colorectal Cancer Cells and Potentiates the Anti-Cancer Effect of 5-FU
Caroline H H Pettersen, Helle Samdal, Pål Sætrom, Arne Wibe, Erland Hermansen, Svanhild A Schønberg, Celso Alves, Marc Diederich · 2023
Read The Salmon Oil OmeGo Reduces Viability of Colorectal Cancer Cells and Potentiates the Anti-Cancer Effect of 5-FU by Caroline H H Pettersen, Helle Samdal, Pål Sætrom, Arne Wibe, Erland Hermansen, Svanhild A Schønberg, Celso Alves, Marc Diederich (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10744414.txt.
Description
Caroline Pettersen and co-authors test whether a salmon oil product can weaken colorectal cancer cells and strengthen a standard chemotherapy drug. Chemotherapy harms healthy cells, so pairing it with a well-tolerated natural product is attractive. The oil carries a spectrum of fats, including the omega-3s EPA and DHA. Four cancer cell lines were treated in the lab.
The oil reduced cell survival in two lines in a dose and time dependent way, and combined treatment with the drug cut survival further. The pure omega-3 pair also reduced survival in all four lines. At the lowest dose, the whole oil outperformed its omega-3 content alone in three lines, suggesting other components help. The authors propose the combination for further study.
Catalog record
| CREATOR | Caroline H H Pettersen, Helle Samdal, Pål Sætrom, Arne Wibe, Erland Hermansen, Svanhild A Schønberg, Celso Alves, Marc Diederich |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |